New York University School of Medicine
New York, 10016, United States
NCT Number: NCT01320800
This 5-year study addresses the unmet needs of adolescents with social phobia through the testing of a 12-week cognitive-behavioral, school-based group intervention delivered by trained school counselors compared to a nonspecific school counseling program. A secondary goal is to provide further examination of the efficacy of the CBT program delivered by school counselors as compared to the same program delivered by psychologists.
Looking for future studies?
Notify Me14 year–17 year
All sexes
Interventional
Phase 2
New York, 10016, United States
The investigators have tested SASS, a school-based group CBT intervention for social phobia, and found it to be effective when delivered by psychologists (Masia Warner et al., 2005; Masia Warner et al., 2007). The proposed dissemination study extends this work through a controlled trial of SASS delivered by school counselors. The investigators will randomize 126 adolescents with social anxiety disorder, ages 14 through 17, to one of 3 treatments: 1) SASS delivered by school counselors (SC-SASS), 2) SASS delivered by psychologists (Expert-SASS), or 3) a manualized adolescent group counseling program specifically designed for school counselors, called Skills for Living (SFL). A comprehensive evaluation will include diagnosis, illness severity, scale ratings of social anxiety and depression, clinical global improvement, overall functioning, and school-relevant indices of function. Outcomes will be assessed at baseline, mid-point (after 6 weeks of intervention), post-treatment, and 6 months following intervention completion.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
12-week cognitive-behavioral, school-based group intervention
SFL is the Skills for Life Protocol delivered by school counselors.
Time frame: 2 week and 6-month follow-up
ADIS CSR Ratings are taken at baseline, immediately following treatment, and at a 6-month followup.
Time frame: 2 week and 6-month follow-up
CGI-I assesses improvement from baseline immediately following treatment and at a 6-month followup assessment.
Time frame: 2 week and 6-month follow-up
Time frame: 2 week and 6-month follow-up
Time frame: 2 week and 6-month follow-up
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06054386
Anxiety Disorders, Mental Disorders
Milwaukee, Wisconsin, United States
View Trial DetailsNCT07562633
Anxiety Disorders, Mental Disorders
Gujranwala, Punjab Province, Pakistan
View Trial DetailsNCT05503017
Anxiety Disorders, Generalized Anxiety Disorder
Tallahassee, Florida, United States
View Trial DetailsNCT03175068
Anxiety Disorders, Depressive Disorder
Chicago, Illinois, United States
View Trial Details